Kymera Therapeutics, Inc. (KYMR)
86.14
-2.86
(-3.21%)
USD |
NASDAQ |
Apr 16, 16:00
86.17
+0.03
(+0.03%)
After-Hours: 20:00
Kymera Therapeutics Free Cash Flow : -234.34M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Gilead Sciences, Inc. | 9.456B |
| Revolution Medicines, Inc. | -913.73M |
| Regeneron Pharmaceuticals, Inc. | 3.765B |
| Structure Therapeutics, Inc. | -226.41M |
| ACADIA Pharmaceuticals, Inc. | 6.308M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -66.75M |
| Cash from Investing (Quarterly) | -394.40M |
| Cash from Financing (Quarterly) | 705.22M |
| Free Cash Flow Per Share (Quarterly) | -0.7435 |
| Free Cash Flow to Equity (Quarterly) | -65.11M |
| Free Cash Flow to Firm (Quarterly) | -66.76M |
| Free Cash Flow Yield | -3.22% |